In Brief: Quidel
This article was originally published in The Gray Sheet
Executive Summary
Quidel: Receives FDA marketing clearance for a point-of-care strep throat test, a "lateral flow immunoassay containing highly specific and sensitive antibodies that are reactive to the strep bacterium." The test is 98% accurate and capable of performing a diagnosis in five minutes "without instrumentation," Quidel says. It will be sold under the brand names Card Q.S. and Concise Performance Plus...